MBCs are typically triple-negative breast cancers (TNBCs), frequently with alterations to genes of the PI3K-AKT-mTOR and RTK-MAPK signaling pathways. This evidence concerns the gene AKT1 and maternal uniparental disomy of chromosome 20.